Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury

Anatomical Record

Volumn 296, Issue 8, 2013, Pages 1229-1246

  Vaughn, Chloe N ^a   Iafrate, Julia L ^a   Henley, Jessica B ^a   Stevenson, Edward K ^a   Shlifer, Igor G ^a   Bucky Jones, T ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adaptive immunity; CNS; Compression; Macrophages; Neuroinflammation; Spinal cord injury

Indexed keywords

CD68 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; CENTRAL GRAY MATTER; CONTROLLED STUDY; DEMYELINATION; FEMALE; GRAY MATTER; IMMUNOREACTIVITY; INNATE IMMUNITY; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SUBARACHNOID SPACE; T LYMPHOCYTE; WALLERIAN DEGENERATION; WHITE MATTER;

ADAPTIVE IMMUNITY; CNS; COMPRESSION; MACROPHAGES; NEUROINFLAMMATION; SPINAL CORD INJURY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE MODELS, ANIMAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, INNATE; LECTINS, C-TYPE; MACROPHAGES; MANNOSE-BINDING LECTINS; MYELITIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES; SURGICAL INSTRUMENTS; T-LYMPHOCYTES; THORACIC VERTEBRAE;

RATTUS;

EID: 84880333941     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22730     Document Type: Article

References (90)

1. Aki K, Shimizu A, Masuda Y, Kuwahara N, Arai T, Ishikawa A, Fujita E, Mii A, Natori Y, Fukunaga Y, Fukuda Y. 2010. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol 298:F870-882.
2. Ankeny DP, Popovich PG. 2009. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 158:1112-1121.
3. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. 2008. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14:1835-1842.
4. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
5. Basso DM, Beattie MS, Bresnahan JC. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
6. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
7. Benedict AL, Mountney A, Hurtado A, Bryan KE, Schnaar RL, Dinkova-Kostova AT, Talalay P. 2012. Neuroprotective effects of sulforaphane after contusive spinal cord injury. J Neurotrauma 29:2576-2586.
8. Bennett CL, Chakraverty R. 2011. Dendritic cells in tissues: in situ stimulation of immunity and immunopathology. Trends Immunol 33:8-13.
9. Blight AR. 1991. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J Neurol Sci 103:156-171.
10. Blight AR. 2002. Miracles and molecules-progress in spinal cord repair. Nat Neurosci 5 Suppl:1051-1054.
11. Chang ML, Wu CH, Chien HF, Jiang-Shieh YF, Shieh JY, Wen CY. 2006. Microglia/macrophages responses to kainate-induced injury in the rat retina. Neurosci Res 54:202-212.
12. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140-147.
13. David S, Kroner A. 2011. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev 12:388-399.
14. Dijkstra CD, Dopp EA, van den Berg TK, Damoiseaux JG. 1994. Monoclonal antibodies against rat macrophages. J Immunol Methods 174:21-23.
15. Donnelly DJ, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG. 2009. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods 181:36-44.
16. Engelhardt B, Ransohoff RM. 2005. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485-495.
17. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143-2155.
18. Fee D, Crumbaugh A, Jacques T, Herdrich B, Sewell D, Auerbach D, Piaskowski S, Hart MN, Sandor M, Fabry Z. 2003. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J Neuroimmunol 136:54-66.
19. Fleming JC, Bao F, Chen Y, Hamilton EF, Relton JK, Weaver LC. 2008. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol 214:147-159.
20. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC. 2006. The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269.
21. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184:1737-1745.
22. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein- reactive CD4+ T cells compared. J Immunol 154:4309-4321.
23. Gensel JC, Donnelly DJ, Popovich PG. 2011. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets 15:505-518.
24. Gensel JC, Nakamura S, Guan Z, van Rooijen N, Ankeny DP, Popovich PG. 2009. Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci 29:3956-3968.
25. Geremia NM, Bao F, Rosenzweig TE, Hryciw T, Weaver L, Dekaban GA, Brown A. 2012. CD11d Antibody treatment improves recovery in spinal cord-injured mice. J Neurotrauma 29:539-550.
26. Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, Meerschaut S, Beschin A, Brombacher F, Raes G. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108:575-583.
27. Gold R, Schmied M, Tontsch U, Hartung HP, Wekerle H, Toyka KV, Lassmann H. 1996. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain 119(Pt 2):651-659.
28. Gonzalez R, Glaser J, Liu MT, Lane TE, Keirstead HS. 2003. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. ExpNeurol 184:456-463.
29. Gordon S. 2003. Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
30. Graeber MB, Streit WJ. 1990. Perivascular microglia defined. Trends Neurosci 13:366.
31. Graeber MB, Streit WJ, Kreutzberg GW. 1989. Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res 22:103-106.
32. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, Goerdt S. 2001. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 53:386-392.
33. Griffiths MR, Gasque P, Neal JW. 2009. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol 68:217-226.
34. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC. 2004. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci 24:4043-4051.
35. Gruner JA, Yee AK, Blight AR. 1996. Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res 729:90-101.
36. Guth L, Barrett CP, Donati EJ, Anderson FD, Smith MV, Lifson M. 1985. Essentiality of a specific cellular terrain for growth of axons into a spinal cord lesion. Exp Neurol 88:1-12.
37. Hadas S, Spira M, Hanisch UK, Reichert F, Rotshenker S. 2012. Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin. J Neuroinflammation 9:166.
38. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, Der Meide PH, Cullheim S, Olsson T, Piehl F. 2000. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20:5283-5291.
39. Hauben E, Agranov E, Gothilf A, Nevo U, Cohen A, Smirnov I, Steinman L, Schwartz M. 2001. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest 108:591-599.
40. Hauben E, Schwartz M. 2003. Therapeutic vaccination for spinal cord injury: helping the body to cure itself. Trends Pharmacol Sci 24:7-12.
41. Hickey WF, Hsu BL, Kimura H. 1991. T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260.
42. Hofstetter HH, Sewell DL, Liu F, Sandor M, Forsthuber T, Lehmann PV, Fabry Z. 2003. Autoreactive T cells promote post-traumatic healing in the central nervous system. J Neuroimmunol 134:25-34.
43. Horn KP, Busch SA, Hawthorne AL, van Rooijen N, Silver J. 2008. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci 28:9330-9341.
44. Huang ZY, Hunter S, Chien P, Kim MK, Han-Kim TH, Indik ZK, Schreiber AD. 2011. Interaction of two phagocytic host defense systems: Fcgamma receptors and complement receptor 3. J Biol Chem 286:160-168.
45. Ibarra A, Correa D, Willms K, Merchant MT, Gui zar-Sahagun G, Grijalva I, Madrazo I. 2003. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res 979:165-178.
46. Ifergan I, Kebir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A. 2008. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131:785-799.
47. Jones TB, Ankeny DP, Guan Z, McGaughy V, Fisher LC, Basso DM, Popovich PG. 2004. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci 24:3752-3761.
48. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG. 2002. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22:2690-2700.
49. Jones TB, McDaniel EE, Popovich PG. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11:1223-1236.
50. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870.
51. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
52. Kostulas N, Li HL, Xiao BG, Huang YM, Kostulas V, Link H. 2002. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33:1129-1134.
53. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. 2001. Identification of the haemoglobin scavenger receptor. Nature 409:198-201.
54. Kuo HS, Tsai MJ, Huang MC, Chiu CW, Tsai CY, Lee MJ, Huang WC, Lin YL, Kuo WC, Cheng H. 2011. Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords. J Neurosci 31:4137-4147.
55. Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, Magnuson DK, Reier PJ, McTigue DM, Popovich PG, Blight AR, Oudega M, Guest JD, Weaver LC, Fehlings MG, Tetzlaff W. 2011. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma 28:1525-1543.
56. Mantovani A, Sica A, Locati M. 2007. New vistas on macrophage differentiation and activation. Eur J Immunol 37:14-16.
57. Mawhinney LA, Thawer SG, Lu WY, Rooijen N, Weaver LC, Brown A, Dekaban GA. 2012. Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J Neuropathol Exp Neurol 71:180-197.
58. Moestrup SK, Moller HJ. 2004. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 36:347-354.
59. Nakajima H, Uchida K, Rodriguez Guerrero A, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright K, Johnson E, Baba H. 2012. Transplantation of mesenchymal stem cells promotes the alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 29:1614-1625.
60. Nashmi R, Fehlings MG. 2001. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 104:235-251.
61. Neumann H, Medana IM, Bauer J, Lassmann H. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25:313-319.
62. Neumann H, Wekerle H. 1998. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 57:1-9.
63. Nguyen DH, Cho N, Satkunendrarajah K, Austin JW, Wang J, Fehlings MG. 2012. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation 9:224.
64. Noble LJ, Wrathall JR. 1985. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol 88:135-149.
65. Pajoohesh-Ganji A, Byrnes KR. 2011. Novel neuroinflammatory targets in the chronically injured spinal cord. Neurotherapeutics 8:195-205.
66. Patro N, Nagayach A, Patro IK. 2010. Iba1 expressing microglia in the dorsal root ganglia become activated following peripheral nerve injury in rats. Indian J Exp Biol 48:110-116.
67. Perry VH. 1998. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90:113-121.
68. Plemel JR, Duncan G, Chen KW, Shannon C, Park S, Sparling JS, Tetzlaff W. 2008. A graded forceps crush spinal cord injury model in mice. J Neurotrauma 25:350-370.
69. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury POPOVICH1999. Exp Neurol 158:351-365.
70. Popovich PG, Hickey WF. 2001. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 60:676-685.
71. Popovich PG, Jones TB. 2003. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 24:13-17.
72. Popovich PG, Longbrake EE. 2008. Can the immune system be harnessed to repair the CNS? Nat Rev 9:481-493.
73. Popovich PG, Wei P, Stokes BT. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats POPOVICH1997A. J Comp Neurol 377:443-464.
74. Potas JR, Zheng Y, Moussa C, Venn M, Gorrie CA, Deng C, Waite PM. 2006. Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J Neurotrauma 23:660-673.
75. Rabchevsky AG, Streit WJ. 1997. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47:34-48.
76. Reichmann G, Schroeter M, Jander S, Fischer H. 2002. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol 129:125.
77. Robins-Steele S, Nguyen DH, Fehlings MG. 2012. The delayed post-injury administration of soluble fas receptor attenuates post-traumatic neural degeneration and enhances functional recovery after traumatic cervical spinal cord injury. J Neurotrauma 29:1586-1599.
78. Rosenzweig ES, McDonald JW. 2004. Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr Opin Neurol 17:121-131.
79. Schaer DJ, Boretti FS, Schoedon G, Schaffner A. 2002. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol 119:239-243.
80. Schmitt AB, Buss A, Breuer S, Brook GA, Pech K, Martin D, Schoenen J, Noth J, Love S, Schroder JM, Kreutzberg GW, Nacimiento W. 2000. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol (Berl) 100:528-536.
81. Schwab JM, Seid K, Schluesener HJ. 2001. Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats. J Neurotrauma 18:881-890.
82. Schwartz M, London A, Shechter R. 2009. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience 158:1133-1142.
83. Serpe CJ, Sanders VM, Jones KJ. 2000. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J Neurosci Res 62:273-278.
84. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, Schwartz M. 2009. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6:e1000113.
85. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462:223-240.
86. Steinman L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 93:2253-2256.
87. Yarom Y, Naparstek Y, Lev-Ram V, Holoshitz J, Ben Nun A, Cohen IR. 1983. Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature 303:246-247.
88. Yu WR, Liu T, Fehlings TK, Fehlings MG. 2009. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur J Neurosci 29:114-131.
89. Zhang Z, Fujiki M, Guth L, Steward O. 1996. Genetic influences on cellular reactions to spinal cord injury: a wound- healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J Comp Neurol 371:485-495.
90. Zhang Z, Krebs CJ, Guth L. 1997. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response. Exp Neurol 143:141-152.